Abstract
The clinical expressions of pheochromocytoma are often dramatic and explosive, and are so variable that it has rightly earned the title of the ‘great mimic’ [1]. One cannot determine histologically whether a pheochromocytoma is benign or malignant. Although only 10% of these neoplasms are pathologically malignant, as evidenced by metastasis or invasion of adjacent tissue, lethal complications from the effects of excessive circulating catecholamines (epinephrine and norepinephrine) almost invariably result if the disease is not appropriately treated. All patients with manifestations even remotely suggestive of pheochromocytoma must be screened for this disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Decourcy JL, Decourcy CB: Pheochromocytomas and the General Practitioner. Cincinnati: Barclay Newman, 1952.
Manger WM, Gifford RW Jr: Pheochromocytoma. New York: Springer-Verlag, 1977.
Winkler H, Smith AD: Pheochromocytomas and other catecholamine-producing tumors. In: Catecholamines, p. 900. Blaschko H, Muscholl E, eds. New York: Springer-Verlag, 1972.
Hermann H, Mornex R: Human Tumours Secreting Catecholamines: Clinical and Physiopathological Study. Oxford: Pergamon, 1964.
Steiner Al, Goodman AD, Powers SR: Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing’s disease: multiple endocrine neoplasia type 2. Medicine 37: 371, 1968.
Thomas JE, Rooke ED, Kvale WF. The neurologist’s experience with pheochromocytoma. A review of 100 cases. J Am Med Assoc. 197: 754, 1966.
Remine WH, Chong GC, van Heerden JA, Sheps SG, Harrison EG Jr: Current management of pheochromocytoma, Ann Surg 179: 740, 1974.
Minno AM, Bennett WA, Kvale WF: Pheochromocytoma; a study of 15 cases diagnosed at autopsy. N Engl J Med 251: 959, 1954.
Aranow H Jr: Pheochromocytoma. In: Monographs in Medicine, p. 179. Bean WE, ed. Series 1. Baltimore: Williams & Wilkins, 1952.
Taubman I, Pearson OH, Anton AH: An asymptomatic catecholamine-secreting pheochromocytoma. Am J Med 57: 953, 1974.
Sjoerdsma A: Sympathoadrenal system: Pheochromocytoma. In: Cecil Loeb Textbook of Medicine. Beeson PB, McDermott W, eds. 13th edn, p. 1832. Philadelphia: W. B. Saunders, 1971.
Engelman K, Zelis R, Waldmann T, Mason DT, Sjoerdsma AM: Mechanism of orthostatic hypertension in pheochromocytoma. Circulation (suppl 6 ) 38: 72, 1968.
Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: their course and prognosis. Am J Med Sci 197: 332, 1939.
Hume DM: Pheochromocytoma in the adult and in the child. Am J Surg 99: 458, 1960.
Leestma JE, Price EB Jr. Paraganglioma of the urinary bladder. Cancer 28: 1063, 1971.
Khairi MR, Dexter RN, Burzynski NJ, Johnston CC Jr: Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: Multiple endocrine neoplasia type 3. Medicine 54: 89, 1975.
Carney JA, Go VL, Sizemore GW, Hayles AB: Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple neoplasia, type 2b. N Engl J Med 295: 1287, 1976.
Carney J A, Sizemore GW, Lovestedt SA. Mucosal ganglioneuromatosis, medullary thyroid carcinoma, and pheochromocytoma: Multiple endocrine neoplasia, Type 2b. Oral Surg 41: 739, 1976.
Chong GC, Beahrs OH, Sizemore GW, Woolner LH: Medullary carcinoma of the thyroid gland. Cancer 35: 695, 1975.
Robertson DM, Sizemore GW, Gordon H. Thickened corneal nerves as a manifestation of multiple endocrine neoplasia. Trans Am Acad Ophthalmol Otolaryngol 79: 772, 1975.
Brasfield RD, Das Gupta TK: Von Recklinghausen’s disease: a clinicopathological study. Ann Surg 175: 86, 1972.
DeQuattro V, Chan S: Raised plasma-catecholamines in some patients with primary hypertension. Lancet 1: 806, 1972.
Stewart BH, Bravo EL, Haaga J, Meaney TF, Tarazi R: Localization of pheochromocytoma by computed tomography. N Engl J Med 299: 460, 1978.
Wallace JM, Gill DP: Prazosin in the diagnosis and treatment of pheochromocytoma. J Am Med Assoc 240: 2752, 1978.
Rosei EA, Brown J J, Lever AF. Treatment of phaeochromocytoma and of Clonidine withdrawal hypertension with labetalol. Br J Clin Pharmacol 3 (suppl 3): 809, 1976.
El-Minawi MF, Paulino E, Cuesta M, Ceballos J: Pheochromocytoma masquerading as pre-eclamptic toxemia. Am J Obstet Gynecol 109: 389, 1971.
Allen CT, Imrie D: Hypoglycemia as a complication of removal of a pheochromocytoma. Can Med Assoc J 116: 363, 1977.
Wilkins GE, Schmidt N, Doll WA. Hypogycemia following excision of pheochromocytoma. Can Med Assoc J 116:367, 1977.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Manger, W.M., Gifford, R.W. (1982). Hypertension Secondary to Pheochromocytoma. In: Amery, A., Fagard, R., Lijnen, P., Staessen, J. (eds) Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Developments in Cardiovascular Medicine, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7476-0_36
Download citation
DOI: https://doi.org/10.1007/978-94-009-7476-0_36
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-7478-4
Online ISBN: 978-94-009-7476-0
eBook Packages: Springer Book Archive